Gene · 7439
Papers1,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Five years' experience of the clinical exome sequencing in a Spanish single center. | Sci Rep | 2022 | 36357507 | PubTator, text mining | PubMed |
| Glutamate Permeability of Chicken Best1. | Exp Neurobiol | 2022 | 36351838 | PubTator, text mining | PubMed |
| Diagnostic yield of next generation sequencing gene panel assays for early-onset glaucoma in an ethnically diverse population. | J AAPOS | 2022 | 36343799 | PubTator, text mining | PubMed |
| Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells. | Arch Toxicol | 2022 | 36326898 | PubTator, text mining | PubMed |
| Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities. | Asian J Pharm Sci | 2022 | 36320315 | PubTator, text mining | PubMed |
| Ocular Gene Therapy: A Literature Review With Focus on Current Clinical Trials. | Cureus | 2022 | 36312652 | PubTator, text mining | PubMed |
| Cell-autonomous lipid-handling defects in Stargardt iPSC-derived retinal pigment epithelium cells. | Stem Cell Reports | 2022 | 36306781 | PubTator, text mining | PubMed |
| Bestrophin-2 and glutamine synthetase form a complex for glutamate release. | Nature | 2022 | 36289327 | PubTator, text mining | PubMed |
| When is a hydrophobic gate not a hydrophobic gate? | J Gen Physiol | 2022 | 36287215 | PubTator, text mining | PubMed |
Identification of numerous novel disease-causing variants in patients with inherited retinal diseases, combining careful clinical-functional phenotyping with systematic, broad NGS panel-based genotyping. | Mol Vis | 2022 | 36284670 | PubTator, text mining | PubMed |
| Temporary Vitelliform Regression After Intravitreal Ranibizumab Injection for Macular Neovascularization Complicating Best Disease. | Int Med Case Rep J | 2022 | 36281445 | PubTator, text mining | PubMed |
| Astrocytes in the initiation and progression of epilepsy. | Nat Rev Neurol | 2022 | 36280704 | PubTator, text mining | PubMed |
| A pathogenic in-frame deletion-insertion variant in BEST1 phenocopies Stargardt disease. | JCI Insight | 2022 | 36264634 | PubTator, text mining | PubMed |
| Using single molecule Molecular Inversion Probes as a cost-effective, high-throughput sequencing approach to target all genes and loci associated with macular diseases. | Hum Mutat | 2022 | 36259723 | PubTator, text mining | PubMed |
| Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy. | Am J Hum Genet | 2022 | 36243009 | PubTator, text mining | PubMed |
| Molecular pathology of Usher 1B patient-derived retinal organoids at single cell resolution. | Stem Cell Reports | 2022 | 36240775 | PubTator, text mining | PubMed |
| Minicircle Delivery to the Neural Retina as a Gene Therapy Approach. | Int J Mol Sci | 2022 | 36232975 | PubTator, text mining | PubMed |
| Cellular and molecular alterations in neurons and glial cells in inherited retinal degeneration. | Front Neuroanat | 2022 | 36225228 | PubTator, text mining | PubMed |
| Combination of Trabeculectomy and Primary Pars Plana Vitrectomy in the Successful Treatment of Angle-Closure Glaucoma with BEST1 Mutations: Self-Controlled Case Series. | Ophthalmol Ther | 2022 | 36223057 | PubTator, text mining | PubMed |
| Utility of No-Charge Panel Genetic Testing for Inherited Retinal Diseases in a Real-World Clinical Setting. | J Vitreoretin Dis | 2022 | 36213299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7439/papers?page=14